Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2023 Jun 7;13:9261. doi: 10.1038/s41598-023-35034-6

Inflammatory markers may mediate the relationship between processed meat consumption and metabolic unhealthy obesity in women: a cross sectional study

Azam Mohamadi 1, Farideh Shiraseb 1, Atieh Mirzababaei 1,, Ahmad Mujtaba Barekzai 2,3,4, Cain C T Clark 5, Yasaman Aali 1, Khadijeh Mirzaei 1,
PMCID: PMC10247747  PMID: 37286588

Abstract

Metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO) are known to be affected by diet and inflammatory factors (such as TGF-β1, IL-β1, MCP1). We sought to survey that consume of processed meat could effect on MHO and MUHO phenotypes, mediated through inflammatory markers, in overweight and obese Iranian women. The current cross-sectional study was done on 224 women 18–48 years, with a body mass index (BMI) ≥ 25 kg/m2. A 147- item food frequency questionnaire (FFQ) was used to evaluate dietary intake. In all participants, anthropometric indices and biochemical factors, as well as metabolic health phenotypes based on Karelis score, were evaluated. According to results, 22.6% of participants had MHO and 75.7% had MUHO phenotypes. There was an association between higher adherence to processed meats and increasing odds of MUHO phenotype in Iranian women (OR:2.54; 95% CI 0.009, 7.51; P = 0.05). Moreover, we found that the relation can be affected by agents such as TGF-β1, IL-β1, and MCP1; however, more research is needed to confirm these results and finding.

Subject terms: Diseases, Medical research

Introduction

Although obesity as a global health problem has metabolic disturbances, there are obese individuals who may have no associated pathologies. This group of individuals have metabolically healthy obesity (MHO) phenotype1. Moreover, metabolically unhealthy obesity (MUHO) phenotype are obese individuals with metabolic abnormalities, such as insulin resistance, hypertension24 or the presence of inflammation markers, such as C-reactive protein (CRP)5,6. The prevalence of MHO is very variable depending on the studies; however, it has been estimated to be 10%-30% worldwide7. MHO appears to be more prevalent in women, and even its prevalence decreases with age in both genders8. The underlying mechanisms causing the metabolic obesity phenotype are multiple and complex; however, we aimed to consider one of the prominent modifiable risk factors, which is diet compositions to reduce the prevalence of this phenotype.

It has been postulated that high-protein diets, specifically, contribute to weight gain or reduction, because they are often rich in red, and other products of, meat, such as processed meats9,10. Processed meats are rich in saturated fatty acid (SFA), cholesterol, sodium and nitrates leading to obesity, and chronic diseases such as diabetes and cancer11,12. It was shown that adherence to a healthy diet such as the consumption of fruits, vegetables, and whole grains is inversely related to chronic disorders (diabetes and CVD), whereas intake of processed meats or sugary drinks is related to raising risk1316. Moreover, it has been posited that the consumption of fast food and organ meats could be associated with unhealthy phenotypes, even in people who were previously metabolically healthy in Iran17. Also, another study indicated the association of a western dietary pattern, consisting of red and processed meats, with obesity phenotype in adults18; whilst in Iranian men, it was found that the intake of meat may be associated with metabolically obese normal weight19. Also, an additional study showed that there could be a relationship between high red and processed meat consumption and insulin resistance and, therefore, MUHO20,21. There are limited studies investigating the association of processed meats and MHO phenotype, instead, they surveyed this relation with different dietary patterns17,22,23.

Furthermore, obesity and inflammation have a strong relationship leading to the inflammatory response triggered by excessive fat mass24,25. It was claimed that metabolically healthy obese and non-obese individuals had lower concentrations of inflammatory markers compared to their metabolically unhealthy counterparts27,28. Also, people with MUHO demonstrated significantly higher hs-CRP than with MHO29. Indeed, it has been shown that a higher intake of red and processed meat was significantly associated with higher C- reactive protein (CRP) in women30. To our knowledge, no study has investigated the extent to which inflammatory markers (TGF-β1, IL-β1, and MCP1) may mediate the relationship between processed meat and MUHO in women. This was the first study to investigate whether processed meat intake could influence MHO and MUHO phenotypes, considering Karelis criteria, mediated by inflammatory markers, in overweight and obese Iranian women. There are even fewer studies specifically worked on the association of processed meats and MUHO phenotype31,32. Thus, it is worthwhile to elucidate this relationship to be able to provide more knowledge and healthier lifestyle.

Methods and materials

Study population

This cross-sectional study was conducted using simple random sampling, where 224 women participants were recruited from 20 Tehran Health Centers. A total sample size of participants was determined by the this formula (([(Z1 − α + Z1 − β) × √1 − r2]/r)2 + 2), β:0.95, α:0.05, with 95% confidence and 80% power, and r:0.25)33. The inclusion criteria were; aged from 18 to 48 years old, with a body mass index (BMI) ≥ 25 kg/m2, lack history of hypertension, no intake of alcohol and opiate drugs, not being pregnant, not having an acute or chronic infection, and exclusion criteria were having a history of CVD, thyroid, cancer, diabetes, liver and kidney disease, and smoking. In addition, participants who had been following any arbitrary/special dietary regimen, as well as those with chronic disease(s) affecting their diet, or if their daily energy intake was < 800 kcal or > 4200 kcal34, were excluded. All participants were asked to provide written consent prior to study commencement. The study was approved by the ethics committee of Tehran University of Medical Sciences (R.TUMS.VCR.REC.1395.1234).

Anthropometric measurements

Body composition, including fat and lean mass, and waist to hip ratio, was assessed by the bioelectric impedance analyzer (In Body 770 scanner, Korea)35. Weight was measured with an accuracy of 100 g using a Seca scale (made in Germany) with the least clothes and without shoes. Also, height was measured to the nearest 0.5 cm by non-elastic tape, subsequently, BMI was calculated as weight (kg) divided by height (m2). WC measurement was performed at the umbilicus, after exhalation, according to standard kin anthropometric guidelines. According to the World Health Organization (WHO) criteria for classification of weight, BMI 25–29.9 kg/m2 was considered as overweight, and BMI 30 kg/m2 or higher as obesity36.

Biochemistry measurements

Blood samples were drawn after 12 h of overnight fasting to assess low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), triglycerides (TG), fasting blood sugar (FBS), total cholesterol, Homeostatic model assessment insulin resistance (HOMA-IR), transforming growth factor-beta 1 (TGF-β1), interleukin- beta 1 (IL- β1), and monocyte chemoattractant protein-1 (MCP-1). The serum was separated and stored at a temperature of -70 °C until the analyses were carried out, after centrifuging.

The HOMA-IR calculation

IR was calculated by the homeostatic model assessment (HOMA) according to the following equation: HOMA-IR ¼ [fasting plasma glucose (mmol/l) fasting plasma insulin (mIU/l)]/22.537.

Metabolic health phenotypes

According to Karelis criteria, the presence of three or more following items indicates metabolic phenotypes:: TG ≤ 1.7 mmol/L or use of lipid-lowering drugs, HDL-C ≥ 1.3 mmol/L, LDL-C ≤ 2.6 mmol/L, HOMA ≤ 2.7, and CRP ≤ 3.0 mg/L38. Then, participants were categorized into two groups, MHO and MUHO39.

Dietary intake measurement

The dietary intake of the women was collected by expert nutritionists who conducted a face-to-face interview with the 147-item semi-quantitative food frequency questionnaire (FFQ), where its validity and reliability have been previously avowed in an Iranian population40. The average consumption frequency was considered over the past year on a daily, weekly, and monthly basis. Household measures were taken into account for portion sizes and then converted to grams41. The food composition table (FCT) of the United States Department of Agriculture (USDA) was used to evaluate energy and nutrients, although the Iranian FCT was considered for local foods that were not present in the USDA FCT. Processed meats were considered as sausage, hamburger, and salami. Moreover, total daily energy intake was examined by considering the sum of each food item's energy.

Physical activity measurement

A valid and reliable international physical activity questionnaire (IPAQ), designed by the WHO and previously validated in Iranian women adults, was used to assess physical activity levels42. The participants were asked to answer questions, such as the time they spent walking, and moderate and vigorous physical activity, during the last week. Subsequently, the time of each physical activity was converted to minutes per week and calculated as the metabolic equivalent of the task (MET/minutes/week).

Other covariates assessments

Demographic characteristics (including age, sex, income, marital status, supplements consumption, socioeconomic status, education, and occupation status) were collected. In addition, systolic and diastolic blood pressure (SBP and DBP) were evaluated after 15-min rest, using a mercury sphygmomanometer.

Statistical analysis

Participants were categorized according to tertiles of processed meat consumption. The Kolmogorov—Smirnov test and histograms were used to determine the distribution of the data. All variables with normal distribution were analyzed by parametric tests. The one-way analysis of variance (ANOVA) for continuous variables and the chi-square test for categorical variables were used to compare subject characteristics and dietary intake across tertiles of the processed meat score, and they were reported as mean (SD). Analysis of covariance (ANCOVA) was used to examine demographic characteristics, anthropometric measurements, clinical assessments, and dietary intake across tertiles of the processed meat score via adjusting for age, BMI, physical activity, energy intake, economic status, and supplement consumption. To examine the association between processed meat score and MHO and MUHO, the binary logistic regression model was applied as an odds ratio (OR) and 95% confidence interval (CI). The Barrett method, Mediation Analysis Model, was implemented for the assessment of the mediating effects of TGF-β1, IL-β1, and MCP1, separately. In the current study, SPSS software version 26 (Chicago—United State) was used for data analysis, whilst a P-value < 0.05 was, a priori, considered statistically significant.

Ethics approval and consent to participate

Each participant was informed completely regarding the study protocol and provided a written and informed consent form before taking part in the study. This study was conducted according to the declaration of Helsinki and all procedures involving human patients were approved by the TUMS. The study protocol was approved by the ethics committee of Tehran University of Medical Sciences (TUMS) with the following identification (R.TUMS.VCR.REC.1395.1234.).

Results

Study population characteristics

In total, 224 women, consisting of 53 MHO (22.6%) and 178 MUHO individuals (75.7%), with mean age and BMI of 36.2 years old and 30.5 kg/m2, respectively, participated in the study. The mean (SD) of MCP1, TGF, and IL-β1 were 52.6 (16.4) pg/ml, 79.4 (66.0) pg/ml, and 2.7 (2.6) pg/ml, respectively.

General characteristics of participants across the tertiles of processed meat scores

General characteristics of participants across the tertiles of processed meat scores in overweight and obese women are shown in Table1. According to the crude model, participants with a lower score of processed meat were more physically active (P = 0.04); however, there were no significant differences between tertiles in other characteristics. After controlling for age, physical activity, and energy intake, we found that socioeconomic status (P = 0.01), supplement use (P = 0.03), LDL-C (P = 0.05), and HDL-C (P = 0.01) had statistically significant mean differences.

Table 1.

General characteristics of participants across tertiles of processed meat (n = 224).

T1 (n = 80) T2 (n = 77) T3 (n = 67) P-value P-value*
Age (year) 36.21 ± 7.64 36.54 ± 9.04 35.83 ± 9.55 0.88
Physical activity (MET/h/w) 1258.16 ± 1500.60 782.49 ± 742.10 948.43 ± 995.59 0.04
Anthropometric measurements
Weight (kg) 80.17 ± 11.13 79.30 ± 10.00 78.56 ± 10.35 0.65 0.53
Height (cm) 161.41 ± 5.81 161.05 ± 6.01 161.32 ± 5.21 0.91 0.65
BMI (kg/m2) 30.70 ± 3.68 30.70 ± 3.44 30.30 ± 3.68 0.75 0.33
WHR 0.93 ± 0.05 0.93 ± 0.04 0.92 ± 0.05 0.83 0.3
Inflammatory markers
TGF-β1 (pg/ml) 73.78 ± 33.99 79.90 ± 38.38 84.34 ± 73.04 0.55 0.66
IL-β1 (pg/ml) 2.73 ± 0.86 2.59 ± 0.94 2.93 ± 1.04 0.48 0.34
MCP1 (pg/ml) 52.04 ± 76.69 57.63 ± 113.64 53.51 ± 99.92 0.94 0.36
Blood pressure measurements
SBP (mm/Hg) 113.41 ± 14.85 110.66 ± 13.39 109.80 ± 13.00 0.26 0.34
DBP (mm/Hg) 78.02 ± 10.99 78.53 ± 9.58 76.85 ± 9.35 0.59 0.71
Biochemistry assessments
TG (mmol/L) 1.39 ± 0.79 1.41 ± 0.78 1.38 ± 0.81 0.96 0.6
cLDL-C (mmol/L) 2.43 ± 0.53 2.45 ± 0.67 2.48 ± 0.67 0.9 0.05
cHDL-C (mmol/L) 1.15 ± 0.27 1.18 ± 0.27 1.24 ± 0.26 0.12 0.01
Total cholesterol (mmol/L) 4.69 ± 0.82 4.80 ± 1.00 4.88 ± 0.97 0.47 0.24
FBS (mmol/L) 4.80 ± 0.53 4.93 ± 0.58 4.85 ± 0.52 0.3 0.4
HOMA-IR 3.23 ± 1.30 3.65 ± 1.28 3.31 ± 1.26 0.1 0.12
¥Socioeconomic status 0.06 0.01
Low 23 (40.0) 20 (34.5) 16 (25.5)
Medium 39 (38.1) 36 (35.1) 28 (26.8)
High 18 (28.8) 21 (33.9) 23 (37.3)
¥Occupation status 0.37 0.45
Unemployed 2 (50.0) 2 (50.0) 0 (0.0)
Employed 78 (35.5) 75 (34.1) 67 (30.5)
¥Marital status 0.17 0.84
Single 21 (32.3) 19 (32.3) 23 (35.5)
Married 59 (36.6) 58 (36.0) 44 (27.3)
¥Education status 0.2 0.83
Low 9 (30.8) 8 (26.9) 13 (42.3)
Diploma 34 (38.6) 30 (34.1) 24 (27.3)
High 37 (34.9) 39 (36.8) 30 (28.3)
¥Supplement use 0.1 0.03
Yes 52 (39.6) 44 (32.1) 40 (28.3)
No 28 (28.6) 33 (37.1) 27 (34.3)

BMI, body mass index; DBP, diastolic blood pressure; FBS, fasting blood sugar; FFM, Fat free mass; HDL, high density lipoprotein; IL- β1, interleukin- beta 1; LDL, low density lipoprotein; MCP1, monocyte chemoattractant protein-1; PDI, overall plant-based diet index; SBP, systolic blood pressure; TGF-β1, transforming growth factor beta 1; WHR, waist hip ratio.

Values are mean ± standard deviation (SD) for continuous variables and number, percentage for dichotomous variables.

Using one-way ANOVA for continuous variables and Chi-square test for categorical variables.

*P-value: adjusted for energy intake, age, physical activity.

aSignificant mean difference between tertiles one and two.

bSignificant mean difference between tertiles one and three.

cSignificant mean difference between tertiles two and three.

¥The variables that were reported in n (%).

P-value < 0.05 significant.

Dietary intake of participants across the tertiles of processed meat scores

Dietary intake of participants across the tertiles of processed meat scores in overweight and obese women are presented in Table 2. Before adjusting for confounding factors, energy intake, all macro-nutrients, as well as cholesterol, SFA, and monounsaturated fatty acid (MUFA) consumption in higher scores of processed meat were significantly lower than the first tertile (P < 0.001). Moreover, participants in the highest tertiles of processed meat had lower intake of linoleic acid, linolenic acid, sodium, potassium, iron, magnesium, calcium, zinc, selenium, vitamin A, β carotene, thiamin, vitamin B6, folate, vitamin B12, total fiber, refined grains, fruits, vegetables, nuts, dairy, and legumes (P < 0.001). Whereas, after controlling for energy intake, the higher consumption of processed meat was only associated with lower intake of magnesium (P = 0.00), total fiber (P = 0.01), and nuts (P = 0.05). However, other dietary factors across tertiles of processed meat showed no significant results before and after adjusting for energy intake.

Table 2.

Dietary intake of participants across tertiles of processed meat.

Mean ± SD P-value P-value*
T1 (n = 80) T2 (n = 78) T3 (n = 67)
Energy intake (kcal/d) 3062.19 ± 568.97 2272.26 ± 614.58 2359.73 ± 786.33  < 0.001
Macronutrients
Protein (g/d) 104.10 ± 21.92 78.97 ± 28.04 79.76 ± 27.23  < 0.001 0.84
Carbohydrate (g/d) 444.52 ± 106.46 323.93 ± 94.59 329.41 ± 118.48  < 0.001 0.36
Total fat (g/d) 107.62 ± 26.18 80.74 ± 29.53 87.57 ± 32.52  < 0.001 0.42
Micronutrients
Cholesterol (mg/d) 296.52 ± 111.14 224.82 ± 82.87 228.15 ± 89.98  < 0.001 0.63
SFA (g/d) 32.59 ± 11.28 23.76 ± 8.92 26.09 ± 11.29  < 0.001 0.76
MUFA (g/d) 34.61 ± 9.28 27.13 ± 11.09 29.45 ± 10.90  < 0.001 0.45
Linoleic acid (g/d) 18.58 ± 6.98 15.21 ± 8.56 16.50 ± 7.92 0.025 0.58
Linolenic acid (g/d) 1.48 ± 0.64 1.05 ± 0.56 1.09 ± 0.57  < 0.001 0.23
Trans fatty acid (g/d) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.23 0.35
Na (mg/d) 4803.63 ± 1333.23 3798.20 ± 1302.93 3913.71 ± 1287.54  < 0.001 0.93
K (mg/d) 5270.56 ± 1245.14 3847.06 ± 1435.79 3825.56 ± 1638.22  < 0.001 0.32
Fe (mg/d) 22.28 ± 4.89 16.28 ± 4.91 16.71 ± 6.09  < 0.001 0.54
Calcium (mg/d) 1381.84 ± 387.82 1038.43 ± 395.07 1020.04 ± 369.27  < 0.001 0.20
Mg (mg/d) 561.12 ± 113.99 405.97 ± 134.34 404.18 ± 143.71  < 0.001 0.00
Zn (mg/d) 15.62 ± 3.13 11.32 ± 3.85 11.69 ± 4.51  < 0.001 0.29
Selenium (mg/d) 136.47 ± 37.45 106.74 ± 40.42 111.88 ± 40.95  < 0.001 0.48
Vitamin A (RAE/d) 963.82 ± 441.71 696.23 ± 330.85 682.44 ± 398.52  < 0.001 0.29
β carotene 6776.13 ± 4265.37 4616.44 ± 2901.09 4498.84 ± 3379.99  < 0.001 0.14
Vitamin D (µg) 2.21 ± 1.89 1.81 ± 1.34 1.80 ± 1.39 0.18 0.80
Vitamin E (mg) 17.47 ± 6.52 16.03 ± 9.67 16.55 ± 9.19 0.55 0.26
Thiamin (mg) 2.37 ± 0.55 1.84 ± 0.57 1.88 ± 0.64  < 0.001 0.64
Vitamin B6 (mg) 2.55 ± 0.56 1.95 ± 0.67 1.93 ± 0.74  < 0.001 0.51
Folate (µg/d) 699.16 ± 153.46 543.19 ± 151.06 551.31 ± 177.90  < 0.001 0.87
Vitamin B12 (µg/d) 5.05 ± 2.33 4.00 ± 2.11 4.04 ± 2.33 0.00 0.76
Total fiber (g/d) 55.58 ± 18.53 38.34 ± 13.20 38.39 ± 17.61  < 0.001 0.01

MUFA, mono unsaturated fatty acid; SFA, saturated fatty acid.

Values are mean ± standard deviation (SD) for continuous variables.

Using one-way ANOVA for continuous variables and Chi-square test for categorical variables.

*Adjusted for energy intake.

P-value < 0.05 significant.

Association of MHO and MUHO phenotype across the tertiles of processed meat scores

The association of MHO and MUHO phenotypes across the tertiles of processed meat scores in overweight and obese women is shown in Table 3. There were no significant associations between MUHO phenotypes with the tertiles of processed meat scores in the crude model (P = 0.26), whilst after adjusting for age, BMI, physical activity, energy intake, women who were in the third tertiles displayed an increased odds ratio but was not statistically significant (P = 0.57). Whereas, after adjustment for age, BMI, physical activity, energy intake, economic status, and supplement consumption, there were increasing odds of MUHO in the third tertile compared to first tertile of processed meat (OR:2.54; 95% CI 0.009, 7.51; P = 0.05). This demonstrated that women with higher scores of processed meats had higher odds of MUHO; however, there was no significant P-trend for this relationship.

Table 3.

Association of metabolic healthy and unhealthy phenotypes with processed meat in overweight and obese women (n = 224).

T1 (n = 80) T2 (n = 77) P- value T3 (n = 67) P- value P- trend
OR 95% CI OR 95% CI
MUHO
Crude model 1 1.10 0.52, 2.31 0.79 1.57 0.71, 3.48 0.26 0.83
Model 1 1 0.86 0.32, 2.27 0.76 1.29 0.52, 3.19 0.57 0.85
Model 2 1 0.80 0.26, 2.40 0.69 2.54 0.009, 7.51 0.05 0.97

CI, confidence interval; MUHO, metabolically unhealthy obesity; OR, odds ratio.

Reference group: Metabolic healthy obesity.

Reference group: First tertiles.

Binary logistic regression was used.

Model 1: adjusted for age, BMI, physical activity, energy intake.

Model 2: adjusted for model 2 further with economic status, supplement consumption.

P-value < 0.05 significant.

Association of MUHO with processed meat scores mediated by inflammatory markers

Association of MHO and MUHO phenotypes across the tertiles of processed meat scores, mediated by inflammatory markers, in overweight and obese women is presented in Table 4. According to Barret model for assessment of mediation effects, three inflammatory markers, including TGF-β1, IL-β1, and MCP1, were included in the models of adjustment. Significant odds of MUHO across the third tertiles of processed meat were attenuated in the inflammatory markers adjusted model. This likely indicates that there was mediator effectiveness of TGF-β1 (P = 0.14), IL-β1 (P = 0.12), and MCP1 (P = 0.48), with increasing odds of MUHO among processed meat tertiles.

Table 4.

Association of MHO and MUHO phenotypes across the tertiles of processed meat scores mediated by inflammatory markers in overweight and obese women (n = 224).

Inflammatory markers T1 (n = 80) T2 (n = 77) T3 (n = 67) P-value
OR 95% CI OR 95% CI
MUHO £TGF-β1 1 0.61 0.13, 2.72 2.20 0.55, 8.80 0.14
IL-β1 1 0.36 0.03, 4.14 15.19 1.18, 194.60 0.12
¥MCP1 1 0.48 0.14, 1.63 2.75 0.84, 8.97 0.48

CI, confidence interval; IL- β1, interleukin- beta 1; MCP1, monocyte chemoattractant protein-1; TGF-β1, transforming growth factor beta 1.

Reference group: Metabolic healthy obesity.

Reference group: First tertiles.

Linear regression was used.

Reference group: Metabolic healthy obesity.

£Adjusted with age, BMI, physical activity, energy intake, economic status, supplement consumption, and TGF-β1.

Adjusted with age, BMI, physical activity, energy intake, economic status, supplement consumption, and IL-β1.

¥Adjusted with age, BMI, physical activity, energy intake, economic status, supplement consumption, and MCP1.

Discussion

In this cross-sectional study, we found that in women with a higher score of processed meat intake, higher odds of MUHO were evident. Moreover, these associations were independent of age, BMI, physical activity, energy intake, thyroid, economic status, and supplement consumption. Additionally, three inflammatory markers, including TGF-β1, IL-β1, and MCP1, were included in the adjusted models.

Participants with higher consumption of processed meats had 2.54 times higher odds of increased MUHO. Processed meats are associated with increased risk of chronic diseases (such as cancer and diabetes) because they have a high content of nitrates, cholesterol, SFA, cholesterol and sodium4345. This result is concordant with many studies. In the American population, individuals with unhealthy and overweight showed significantly higher intake of red meat, processed meat and fried foods when compared with those with metabolically healthy and normal weight4648. In a study by Pereira et al., unhealthy pattern was positively associated with the metabolically healthy and metabolically unhealthy and overweight phenotypes in the fourth quartile and in the third and fourth quartiles of consumption22. The cross-sectional study among 6964 women showed that metabolically unhealthy but normal-weight subjects had a significantly greater consumption of processed meat, red meat, and fried foods, compared to women who were metabolically healthy and normal weight49.The Soltani et al. study showed a direct association between greater adherence to a pro-inflammatory diet and increase odds of unhealthy phenotype, high FBS, and also a relation to low-HDL-C levels in overweight and obese participants23. There was a relation between more consumption of dairy products, poultry, apples/pears, citrus fruits, magnesium, and tea/coffee and diminished risk of developing an unhealthy phenotype, but greater consumption of organ meats, potatoes, and fast foods can raise the risk of metabolic obesity50. A cohort study illustrated that metabolically healthy obesity was related to the risk of an unhealthy diet, and also there was a relation between high consumption of processed meat and raising the risk of unhealthy phenotype obesity, there was a relationship between more energy-content food patterns and high adherence to an unhealthy diet and raising risks such as metabolic disturbance and obesity5155. Intake of red and processed meats also decreased with the increaseing tertiles, as reported in previous studies an unhealthy diet is related to a higher odds of metabolically unhealthy, which includes consuming more solid fats, red meat are known39. In a study that examined the association between a healthy plant-based diet and metabolic obesity phenotype with the mediating role of inflammatory factors such as TGF-β1, IL-β1, and MCP1, more adherence to healthful plant-based diet index had a considerably lower risk for the MUHO phenotype in women56. Increases in circulating inflammatory markers, such as transforming TGF-β1, IL- β1, and MCP-1, are known to contribute to metabolic diseases26. In Iranian men, it was found that it is possible that higher meat consumption was related to metabolically obese normal weight57.

Overall, the intake of meat is related to increase plasma concentration of iron that may contribute to the enhancement of oxidative stress and inflammatory mediators58. Also, it contains a high level of advanced glycation end products that are produced during the food preparation process59,60. Advanced glycation end products have pro-inflammatory functions, and increased inflammatory mediators can increase insulin resistance in tissues61. Whereas intake of healthy diet has been shown to be a direct relation with the MHO phenotype62. The SFAs in processed meats, leading to decreased insulin sensitivity63. Indeed, it was claimed that metabolically healthy obese and non-obese individuals had lower concentrations of inflammatory markers, compared to their metabolically unhealthy counterparts27,28. In addition, participants with MUHO demonstrated significantly higher hs-CRP than MHO29.

Our study includes several strengths, such as the use of different quality assurance and quality control strategies, and the use of an FFQ developed and validated for the population assessed. As well, to our knowledge, this represents the first investigation into the association between processed meat consumption and healthy and unhealthy metabolic phenotype obesity among Iranian women. Among the limitations, information bias cannot be ruled out since, as already pointed out, the under-or over-reporting of foods composing the dietary patterns, especially among obese individuals, may have contributed to the positive associations observed. Additionally, the relatively small sample size should be addressed in the future.

Conclusion

We found that women with higher consumption of processed meat had higher odds of MUHO. Prospective and interventional studies in both genders, different populations and ethnicities need to be conducted to further the knowledge about examin inflammatory markers (TGF-β1, IL-β1, and MCP1) may mediate the relationship between processed meat and MUHO.

Abbreviations

BMI

Body mass index

DBP

Diastolic blood pressure

FBS

Fasting blood sugar

HDL

High density lipoprotein

IL- β1

Interleukin-beta 1

LDL

Low density lipoprotein

MCP1

Monocyte chemoattractant protein-1

SBP

Systolic blood pressure

TGF-β1

Transforming growth factor beta 1

WHR

Waist hip ratio

MUFA

Mono unsaturated fatty acid

PUFA

Poly saturated fatty acid

SFA

Saturated fatty acid

CI

Confidence interval

MUHO

Metabolically unhealthy obesity

OR

Odds ratio

MHO

Metabolic healthy obesity

WC

Waist circumference

DASH

Dietary approaches to stop hypertension

CRP

C-reactive protein

WHO

World Health Organization

HOMA-IR

Homeostatic model assessment-insulin resistance

FFQ

Food frequency questionnaire

FCT

Food composition table

TGF-β1

Transforming growth factor-beta 1

USDA

United States Department of Agriculture

IPAQ

Physical activity questionnaire

MetS

Metabolic syndrome

FFAs

Free fatty acids

NHANES

The National Health and Nutrition Examination Survey

Author contributions

A.M. (AM1), A.M. (AM2), K.M. (KhM) designed the search; AM2, conducted the sampling; F.S. (FSH) performed statistical analysis; AM1, A.M.B., C.C. (CC), Y.A, (YA) and K.M. wrote the paper, K.M. has primary responsibility for- the final content. All authors read and approved the final manuscript. All authors approved the final manuscript and consent for publication.

Funding

This study was supported by TUMS.

Data availability

The all authors declare that the data supporting the results of this study are provided in present article, and all the data in the present study will be available with the opinion of the corresponding author.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Atieh Mirzababaei, Email: ati_babaee@yahoo.com.

Khadijeh Mirzaei, Email: mirzaei_kh@sina.tums.ac.ir.

References

  • 1.Gómez-Zorita S, Queralt M, Vicente MA, González M, Portillo MP. Metabolically healthy obesity and metabolically obese normal weight: A review. J. Physiol. Biochem. 2021;77:175–189. doi: 10.1007/s13105-020-00781-x. [DOI] [PubMed] [Google Scholar]
  • 2.Blüher M. The distinction of metabolically ‘healthy’from ‘unhealthy’obese individuals. Curr. Opin. Lipidol. 2010;21(1):38–43. doi: 10.1097/MOL.0b013e3283346ccc. [DOI] [PubMed] [Google Scholar]
  • 3.Blüher M. Mechanisms in endocrinology: Are metabolically healthy obese individuals really healthy? Eur. J. Endocrinol. 2014;171(6):R209–R219. doi: 10.1530/EJE-14-0540. [DOI] [PubMed] [Google Scholar]
  • 4.Stefan N, Häring H-U, Hu FB, Schulze MB. Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1(2):152–162. doi: 10.1016/S2213-8587(13)70062-7. [DOI] [PubMed] [Google Scholar]
  • 5.Karelis AD, Rabasa-Lhoret R. Can inflammatory status define metabolic health? Nat. Rev. Endocrinol. 2013;9(12):694–695. doi: 10.1038/nrendo.2013.198. [DOI] [PubMed] [Google Scholar]
  • 6.Karelis A, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 2004;30(6):569–572. doi: 10.1016/S1262-3636(07)70156-8. [DOI] [PubMed] [Google Scholar]
  • 7.Muñoz-Garach A, Cornejo-Pareja I, Tinahones FJ. Does metabolically healthy obesity exist? Nutrients. 2016;8(6):320. doi: 10.3390/nu8060320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.van Vliet-Ostaptchouk JV, Nuotio M-L, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: A collaborative analysis of ten large cohort studies. BMC Endocr. Disord. 2014;14(1):1–13. doi: 10.1186/1472-6823-14-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Clifton P. Effects of a high protein diet on body weight and comorbidities associated with obesity. Br. J. Nutr. 2012;108(S2):S122–S129. doi: 10.1017/S0007114512002322. [DOI] [PubMed] [Google Scholar]
  • 10.Halkjær J, Olsen A, Overvad K, Jakobsen MU, Boeing H, Buijsse B, et al. Intake of total, animal and plant protein and subsequent changes in weight or waist circumference in European men and women: The Diogenes project. Int. J. Obes. 2011;35(8):1104–1113. doi: 10.1038/ijo.2010.254. [DOI] [PubMed] [Google Scholar]
  • 11.Schulze M, Manson J, Willett W, Hu F. Processed meat intake and incidence of type 2 diabetes in younger and middle-aged women. Diabetologia. 2003;46:1465–1473. doi: 10.1007/s00125-003-1220-7. [DOI] [PubMed] [Google Scholar]
  • 12.Bes-Rastrollo M, Sánchez-Villegas A, Gómez-Gracia E, Martínez JA, Pajares RM, Martínez-González MA. Predictors of weight gain in a Mediterranean cohort: The Seguimiento Universidad de Navarra study. Am. J. Clin. Nutr. 2006;83(2):362–370. doi: 10.1093/ajcn/83.2.362. [DOI] [PubMed] [Google Scholar]
  • 13.Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am. J. Clin. Nutr. 2006;84(6):1489–1497. doi: 10.1093/ajcn/84.6.1489. [DOI] [PubMed] [Google Scholar]
  • 14.Esmaillzadeh A, Mirmiran P, Azizi F. Whole-grain consumption and the metabolic syndrome: A favorable association in Tehranian adults. Eur. J. Clin. Nutr. 2005;59(3):353–362. doi: 10.1038/sj.ejcn.1602080. [DOI] [PubMed] [Google Scholar]
  • 15.Feskens EJ, Sluik D, van Woudenbergh GJ. Meat consumption, diabetes, and its complications. Curr. Diab.Rep. 2013;13:298–306. doi: 10.1007/s11892-013-0365-0. [DOI] [PubMed] [Google Scholar]
  • 16.Greenwood D, Threapleton D, Evans C, Cleghorn C, Nykjaer C, Woodhead C, et al. Association between sugar-sweetened and artificially sweetened soft drinks and type 2 diabetes: Systematic review and dose–response meta-analysis of prospective studies. Br. J. Nutr. 2014;112(5):725–734. doi: 10.1017/S0007114514001329. [DOI] [PubMed] [Google Scholar]
  • 17.Mirmiran P, Moslehi N, Hosseinpanah F, Sarbazi N, Azizi F. Dietary determinants of unhealthy metabolic phenotype in normal weight and overweight/obese adults: Results of a prospective study. Int. J. Food Sci. Nutr. 2020;71(7):891–901. doi: 10.1080/09637486.2020.1746955. [DOI] [PubMed] [Google Scholar]
  • 18.Paradis A-M, Godin G, Pérusse L, Vohl M-C. Associations between dietary patterns and obesity phenotypes. Int. J. Obes. 2009;33(12):1419–1426. doi: 10.1038/ijo.2009.179. [DOI] [PubMed] [Google Scholar]
  • 19.Hashemipour S, Esmailzadehha N, Mohammadzadeh M, Ziaee A. Association of meat and dairy consumption with normal weight metabolic obesity in men: The Qazvin metabolic diseases study. Eat. Weight Disord.-Stud. Anorexia, Bulim. Obes. 2016;21(3):419–425. doi: 10.1007/s40519-015-0250-8. [DOI] [PubMed] [Google Scholar]
  • 20.Zelber-Sagi S, Ivancovsky-Wajcman D, Isakov NF, Webb M, Orenstein D, Shibolet O, et al. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. J. Hepatol. 2018;68(6):1239–1246. doi: 10.1016/j.jhep.2018.01.015. [DOI] [PubMed] [Google Scholar]
  • 21.Hoddy KK, Axelrod CL, Mey JT, Hari A, Beyl RA, Blair JB, et al. Insulin resistance persists despite a metabolically healthy obesity phenotype. Obesity. 2022;30(1):39–44. doi: 10.1002/oby.23312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Pereira DL, Juvanhol LL, Silva DC, Longo GZ. Dietary patterns and metabolic phenotypes in Brazilian adults: A population-based cross-sectional study. Public Health Nutr. 2019;22(18):3377–3383. doi: 10.1017/S1368980019002593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Soltani, S., Moslehi, N., Hosseini-Esfahani, F., Vafa, M. The association between empirical dietary inflammatory pattern and metabolic phenotypes in overweight/obese adults. Int. J. Endocrinol. Metab.16(2), (2018). [DOI] [PMC free article] [PubMed]
  • 24.Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011;29:415–445. doi: 10.1146/annurev-immunol-031210-101322. [DOI] [PubMed] [Google Scholar]
  • 25.Kim C, Park H, Kawada T, Kim JH, Lim D, Hubbard N, et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int. J. Obes. 2006;30(9):1347–1355. doi: 10.1038/sj.ijo.0803259. [DOI] [PubMed] [Google Scholar]
  • 26.Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J. Clin. Investig. 2011;121(6):2111–2117. doi: 10.1172/JCI57132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Cheng D, Zhao X, Yang S, Cui H, Wang G. Metabolomic signature between metabolically healthy overweight/obese and metabolically unhealthy overweight/obese: A systematic review. Diabetes, Metab. Syndr. Obes. Targets Ther. 2021;14:991. doi: 10.2147/DMSO.S294894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults? J. Clin. Endocrinol. Metab. 2013;98(10):E1610–E1619. doi: 10.1210/jc.2013-2038. [DOI] [PubMed] [Google Scholar]
  • 29.Tsou M-T, Yun C-H, Lin J-L, Sung K-T, Tsai J-P, Huang W-H, et al. Visceral adiposity, pro-inflammatory signaling and vasculopathy in metabolically unhealthy non-obesity phenotype. Diagnostics. 2020;11(1):40. doi: 10.3390/diagnostics11010040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Chai W, Morimoto Y, Cooney RV, Franke AA, Shvetsov YB, Le Marchand L, et al. Dietary red and processed meat intake and markers of adiposity and inflammation: The multiethnic cohort study. J. Am. Coll. Nutr. 2017;36(5):378–385. doi: 10.1080/07315724.2017.1318317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Farhadnejad H, Darand M, Teymoori F, Asghari G, Mirmiran P, Azizi F. The association of dietary approach to stop hypertension (DASH) diet with metabolic healthy and metabolic unhealthy obesity phenotypes. Sci. Rep. 2019;9(1):18690. doi: 10.1038/s41598-019-55285-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tang D, Xiao X, Chen L, Kangzhu Y, Deng W, Yang S, et al. Association of dietary patterns with obesity and metabolically healthy obesity phenotype in Chinese population: A cross-sectional analysis of China multi-ethnic cohort study. Br. J. Nutr. 2022;128(11):2230–2240. doi: 10.1017/S0007114521005158. [DOI] [PubMed] [Google Scholar]
  • 33.Askarpour M, Sheikhi A, Khorsha F, Mirzaei K. Associations between adherence to MIND diet and severity, duration and frequency of migraine headaches among migraine patients. BMC. Res. Notes. 2020;13(1):1–6. doi: 10.1186/s13104-020-05181-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Willett, W. Issues in analysis and presentation of dietary data. Nutr. Epidemiol. 321–46 (1998).
  • 35.Mirzababaei A, Shiraseb F, Abaj F, Khosroshahi RA, Tavakoli A, Koohdani F, et al. The effect of dietary total antioxidant capacity (DTAC) and Caveolin-1 gene variant interaction on cardiovascular risk factors among overweight and obese women: A cross-sectional investigation. Clin. Nutr. 2021;40(8):4893–4903. doi: 10.1016/j.clnu.2021.07.013. [DOI] [PubMed] [Google Scholar]
  • 36.WHO. https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi.
  • 37.Mirzaei K, Hossein-Nezhad A, Keshavarz S, Eshaghi S, Koohdani F, Saboor-Yaraghi A, et al. Insulin resistance via modification of PGC1α function identifying a possible preventive role of vitamin D analogues in chronic inflammatory state of obesity. A double blind clinical trial study. Minerva Med. 2014;105(1):63–78. [PubMed] [Google Scholar]
  • 38.Karelis A, Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab. 2008;34(2):183–184. doi: 10.1016/j.diabet.2007.11.004. [DOI] [PubMed] [Google Scholar]
  • 39.Mirzababaei A, Sajjadi SF, Ghodoosi N, Pooyan S, Arghavani H, Yekaninejad MS, et al. Relations of major dietary patterns and metabolically unhealthy overweight/obesity phenotypes among Iranian women. Diabetes Metab. Syndr. 2019;13(1):322–331. doi: 10.1016/j.dsx.2018.09.012. [DOI] [PubMed] [Google Scholar]
  • 40.Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–662. doi: 10.1017/S1368980009991698. [DOI] [PubMed] [Google Scholar]
  • 41.Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran Nashre Olume Keshavarzy. 1999;7(213):42–58. [Google Scholar]
  • 42.Bassett DR., Jr International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports Exerc. 2003;35(8):1396. doi: 10.1249/01.MSS.0000078923.96621.1D. [DOI] [PubMed] [Google Scholar]
  • 43.Henderson L, Gregory J, Swan G. The National Diet and Nutrition Survey: adults aged 19 to 64 years. Vitam. Miner. Intake Urin. Anal. 2003;3:1–8. [Google Scholar]
  • 44.Schulze M, Manson J, Willett W, Hu F. Processed meat intake and incidence of type 2 diabetes in younger and middle-aged women. Diabetologia. 2003;46(11):1465–1473. doi: 10.1007/s00125-003-1220-7. [DOI] [PubMed] [Google Scholar]
  • 45.Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R. A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med. 2007;4(12):e325. doi: 10.1371/journal.pmed.0040325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Fung TT, Rimm EB, Spiegelman D, Rifai N, Tofler GH, Willett WC, et al. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am. J. Clin. Nutr. 2001;73(1):61–67. doi: 10.1093/ajcn/73.1.61. [DOI] [PubMed] [Google Scholar]
  • 47.Kimokoti RW, Judd SE, Shikany JM, Newby P. Food intake does not differ between obese women who are metabolically healthy or abnormal. J. Nutr. 2014;144(12):2018–2026. doi: 10.3945/jn.114.198341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kimokoti RW, Judd SE, Shikany JM, Newby P. Metabolically healthy obesity is not associated with food intake in white or black men. J. Nutr. 2015;145(11):2551–2561. doi: 10.3945/jn.115.221283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Bell LK, Edwards S, Grieger JA. The relationship between dietary patterns and metabolic health in a representative sample of adult Australians. Nutrients. 2015;7(8):6491–6505. doi: 10.3390/nu7085295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Abiri, B., Valizadeh, M., Nasreddine, L., Hosseinpanah, F. Dietary determinants of healthy/unhealthy metabolic phenotype in individuals with normal weight or overweight/obesity: a systematic review. Crit. Rev. Food Sci. Nutr. 1–18 (2022). [DOI] [PubMed]
  • 51.Kratz M, Baars T, Guyenet S. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur. J. Nutr. 2013;52(1):1–24. doi: 10.1007/s00394-012-0418-1. [DOI] [PubMed] [Google Scholar]
  • 52.Magkos F. Metabolically healthy obesity: what's in a name? Am. J. Clin. Nutr. 2019;110(3):533–539. doi: 10.1093/ajcn/nqz133. [DOI] [PubMed] [Google Scholar]
  • 53.Stanhope KL. Sugar consumption, metabolic disease and obesity: The state of the controversy. Crit. Rev. Clin. Lab. Sci. 2016;53(1):52–67. doi: 10.3109/10408363.2015.1084990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Xie X, Guo B, Xiao X, Yin J, Wang Z, Jiang X, et al. Healthy dietary patterns and metabolic dysfunction-associated fatty liver disease in less-developed ethnic minority regions: A large cross-sectional study. BMC Public Health. 2022;22(1):1–14. doi: 10.1186/s12889-021-12486-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Zhou Z, Macpherson J, Gray SR, Gill JM, Welsh P, Celis-Morales C, et al. Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants. Diabetologia. 2021;64(9):1963–1972. doi: 10.1007/s00125-021-05484-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Mohamadi, A., Shiraseb, F., Mirzababaei, A., Hosseininasab, D., Rasaei, N., Clark, C. C., et al. Circulating inflammatory markers may mediate the relationship between healthy plant-based diet and metabolic phenotype obesity in women: A cross-sectional study. Int. J. Clin. Pract.2022, (2022). [DOI] [PMC free article] [PubMed]
  • 57.Hashemipour S, Esmailzadehha N, Mohammadzadeh M, Ziaee A. Association of meat and dairy consumption with normal weight metabolic obesity in men: The qazvin metabolic diseases study. Eat. Weight Disord.-Stud. Anorexia, Bulimia Obes. 2016;21:419–425. doi: 10.1007/s40519-015-0250-8. [DOI] [PubMed] [Google Scholar]
  • 58.Fernández-Real JM, López-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes. 2002;51(8):2348–2354. doi: 10.2337/diabetes.51.8.2348. [DOI] [PubMed] [Google Scholar]
  • 59.Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann. N. Y. Acad. Sci. 2005;1043(1):461–466. doi: 10.1196/annals.1333.052. [DOI] [PubMed] [Google Scholar]
  • 60.Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Dietetic Assoc. 2010;110(6):911–6.e12. doi: 10.1016/j.jada.2010.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Lee C, Adler A, Sandhu M, Sharp S, Forouhi N, Erqou S, et al. Association of C-reactive protein with type 2 diabetes: Prospective analysis and meta-analysis. Diabetologia. 2009;52:1040–1047. doi: 10.1007/s00125-009-1338-3. [DOI] [PubMed] [Google Scholar]
  • 62.Slagter SN, Corpeleijn E, Van Der Klauw MM, Sijtsma A, Swart-Busscher LG, Perenboom CW, et al. Dietary patterns and physical activity in the metabolically (un) healthy obese: The Dutch Lifelines cohort study. Nutr. J. 2018;17(1):1–14. doi: 10.1186/s12937-018-0319-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Paniagua JA, De La Sacristana AG, Romero I, Vidal-Puig A, Latre J, Sanchez E, et al. Monounsaturated fat–rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabet. Care. 2007;30(7):1717–1723. doi: 10.2337/dc06-2220. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The all authors declare that the data supporting the results of this study are provided in present article, and all the data in the present study will be available with the opinion of the corresponding author.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES